Arcutis Therapeutics has successfully tested its own drug roflumilast foam in patients with the scalp and body psoriasis.
A European regulatory body will consider Merck's tepotinib for use in certain types of tumors.
The first clinical trial of Nanoform Piroxicam manuractured by the Finnish company will begin at the end of 2020.
Scientists from Sweden Karolinska Institute have found that a common and often prescribed antidepressant can stop the growth of a malignant tumor.
Scientists have discovered a bacterial toxin that promotes tissue healing.
The company "Ananta Medicare" supported the holding of the rheumatology school and took part in it. More than 1,500 doctors have got acquainted with the materials of the school remotely.
Scientists from the United States have found that a certain class of antibiotics could be promising for the treatment of frontotemporal dementia.
By using a new approach, scientists have developed an experimental vaccine against Toxoplasma gondii.